HOME >> MEDICINE >> NEWS
'Biochemical storm' following brain trauma, an important factor in treatment

Oct. 28, 1999, GAINESVILLE---A forceful blow to the head can trigger a "Pacman-like" enzyme to begin gobbling up important structural proteins in the brain for up to one month afterward -- weeks longer than previously suspected, according to a University of Florida Brain Institute researcher.

The finding, based on studies in rats, suggests that treatment for traumatic brain injury must take into account tissue damage that continues to occur long after an accident. Although a number of studies recently have assessed therapies for traumatic brain injury, currently no effective treatment exists. "Emergency room medical personnel often talk about a golden hour, that if you don't get a person into treatment within the first hour or so after an injury, a lot of damage has been done to the patient," said Ronald L. Hayes, director of UF's planned Center for Traumatic Brain Injury Studies, a component of the university's multidisciplinary Brain Institute. "With traumatic brain injury, the thought has been that treatment within the first two days is critical." But data from Hayes' lab suggest this critical period may extend much longer.

"In our studies, we've found that a biochemical storm that is initiated with an injury continues for at least a month. The implication is that we may need to treat these patients over a much longer period than anyone had ever imagined," said Hayes, who reported his findings on the action of calpains on Saturday (10/23) at the annual meeting of the National Neurotrauma Society in Miami Beach. Calpains are a type of protein-destroying enzyme found in cells throughout the body.

"This is one of a very few research efforts that opens up a potential window for treatment in which we might be able to suppress the harmful activity of calpains while allowing repair to occur," said Kevin Wang, a senior research associate at Parke-Davis Pharmaceutical Research who is conducting laboratory experiments seeking to block the action of calpa
'"/>

Contact: Victoria White
vickiwhite@xtalwind.net
352-344-2738
University of Florida
27-Oct-1999


Page: 1 2 3

Related medicine news :

1. US FDA grants full approval to DOXIL(R) following submission of phase III data
2. Patients with abdominal trauma at risk for intra-abdominal infections following surgery
3. Guidelines for following pediatric cancer survivors aim to reduce medical complications
4. Can the standard course of radiation therapy following lumpectomy be shortened?
5. Higher incidence of rejection following early steroid withdrawal
6. Impaired neuromotor function following cancer treatment can improve
7. Significant pain relief following gastric bypass surgery
8. Carbon monoxide from smoking helps keep arteries open following angioplasty
9. CellCept associated with reduced incidence of cancer, compared to AZA, following heart transplant
10. Study shows lower than expected allergic-like events following second prescription of penicillin
11. Hospitals following heart attack guidelines have better outcomes

Post Your Comments:
(Date:12/22/2014)... Luxury Linen purveyor Peacock Alley once ... to provide logistics and support for one of Dallas’ largest ... long history of giving back to the community in which ... Toy Drive were Whataburger® and 99.5 The Wolf. , There ... Providing gifts to children who would otherwise not receive any ...
(Date:12/22/2014)... NAPW honors Michelle ... the Year. Ms. Foley is recognized with this prestigious ... networking organization of professional women in the country, spanning ... Professional Women is a powerfully vibrant networking community with ... “As a nurse, I felt like I made a ...
(Date:12/22/2014)... BROOK, Ill. (PRWEB) December 21, 2014 ... radiologist recommendations for chest computed tomography (CT) to ... clinically relevant findings, including cancer, according to a ... , Researchers said the findings show that ... X-rays represent valuable contributions to patient care. , ...
(Date:12/22/2014)... DC (PRWEB) December 22, 2014 ... Leadership Conference, next month in San Antonio, ... to address dynamics that often stand in the ... and competition. , This premier faculty development ... for Transformational Leadership, whose mission is to assist ...
(Date:12/21/2014)... In this report, the global powered surgical instruments ... application. The market, by power source, is segmented ... the market covers the handpieces; power source and ... further subdivided into drills, saws, reamers, staplers, vessel ... drivers, and others. Moreover, the power source and ...
Breaking Medicine News(10 mins):Health News:Peacock Alley and Community Partners of Dallas Fulfill an Estimated 12,000 Holiday Wishes for Deserving Children 2Health News:National Association of Professional Women Announces Michelle M. Foley, Vice President of Operations of OTTR Chronic Care Solutions, a 2014 Professional Woman of the Year 2Health News:RSNA: Radiologist Recommendations for Chest CT Have High Clinical Yield 2Health News:RSNA: Radiologist Recommendations for Chest CT Have High Clinical Yield 3Health News:2015 NLN Leadership Conference February 5-7 San Antonio 2Health News:2015 NLN Leadership Conference February 5-7 San Antonio 3Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 3Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 4
(Date:12/22/2014)... Research and Markets ( http://www.researchandmarkets.com/research/hmlfbq/investment ... "Investment Analysis of the US Medical Device Sector ... http://photos.prnewswire.com/prnh/20130307/600769 This ... sector identifies the key trends and rationale for ... mergers and acquisitions. The study will ...
(Date:12/22/2014)... CHESTERBROOK, Pa. and STOCKHOLM ... AB (publ) (Sobi) and partner Auxilium Pharmaceuticals, Inc. today ... Use (CHMP) of the European Medicines Agency (EMA) has ... (collagenase clostridium histolyticum) for the treatment of adult men ... deformity of at least 30 degrees at the start ...
(Date:12/22/2014)... 2014  Eiger BioPharmaceuticals Incorporated announced the positive ... in patients with chronic hepatitis delta virus (HDV) ... Institutes of Health (NIH) Clinical Center in ... placebo-controlled, dose ascending study evaluated two doses of ... twice daily for 28 days.  "This proof-of-concept study ...
Breaking Medicine Technology:Investment Analysis of the US Medical Device Sector 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3
Cached News: